Previous studies using mouse models with reversible p53 expression in distinct cancer contexts report a uniform response to p53 reactivation, with tumors either undergoing a senescence response followed by immune-mediated tumor clearance or apoptotic cell death15–20. The gene discussed is TP53; the disease is neoplasm.